In Vitro Radiosensitization of Esophageal Cancer Cells with the Aminopeptidase Inhibitor CHR-2797

With the increased incidence of esophageal cancer, chemoradiotherapy continues to play an important role in the management of this disease. Developing potent radiosensitizers is therefore critical for improving outcomes. The use of drugs that have already undergone clinical testing is an appealing a...

Full description

Saved in:

Bibliographic Details
Published in:	Radiation research Vol. 184; no. 3; pp. 259 - 265
Main Authors:	Anbalagan, Selvakumar, Biasoli, Deborah, Leszczynska, Katarzyna B., Mukherjee, Somnath, Hammond, Ester M.
Format:	Journal Article
Language:	English
Published:	United States The Radiation Research Society 01.09.2015 Radiation Research Society Allen Press Inc
Subjects:	Aminopeptidases - antagonists & inhibitors Biotechnology Cancer Cell Line, Tumor Deoxyribonucleic acid DNA Esophageal Neoplasms - pathology Esophageal Neoplasms - radiotherapy Glycine - analogs & derivatives Glycine - pharmacology Humans Hydroxamic Acids - pharmacology In vitro testing Inhibitors Management Radiation-Sensitizing Agents - pharmacology Radiosensitizers REGULAR ARTICLE REGULAR ARTICLES Side effects
ISSN:	0033-7587, 1938-5404, 1938-5404
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!